Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-19-015 from the NIH Guide for Grants and Contracts. This FOA invites applications that propose the comprehensive functional validation of newly identified therapeutic target candidates for Alzheimer's Disease-Related Dementias (ADRDs). This FOA seeks to promote critical target validation approaches to help de-risk subsequent translational research and accelerate the advancement of novel therapies for ADRD. Target(s) or molecular pathway(s) to be considered for validation must have been already identified using tissue expression or genetic data generated in human samples. In its initial phase, ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 6, 2019 Category: Research Source Type: funding
Clinical and Biological Measures of TBI-related dementia including Chronic Traumatic Encephalopathy (CTE) (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-19-026 from the NIH Guide for Grants and Contracts. This FOA invites investigation of biological and clinical measures of TBI-related progressive neurodegeneration and neurocognitive decline associated with increased risk for dementia and /or traumatic encephalopathy syndrome (TES) (clinicopathologic diagnostic counterpart to the neuropathological diagnosis of Chronic Traumatic Encephalopathy (CTE)). The overall goal is to advance knowledge of the underlying pathophysiology and clinical characterization of the chronic effects of TBI that distinguish static-chronic TBI cognitive impairment from...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 25, 2019 Category: Research Source Type: funding
Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States Including in Health Disparities Populations (U19 Clinical Trial not Allowed)
Funding Opportunity RFA-NS-19-012 from the NIH Guide for Grants and Contracts. The National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (NIA) intend to publish a Funding Opportunity Announcement (FOA) to solicit applications for a large prospective clinical research study to determine the specific subsets of stroke events that predict cognitive impairment and dementia in post-stroke populations in the United States, including in health disparities populations, and what additional clinical factors and comorbidities along the AD/ADRD spectrum may causally synergize with stroke to...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 15, 2019 Category: Research Source Type: funding
Alzheimer's Disease Programs Initiative - Grants to States and Communities
Grants to support the development and expansion of dementia-capable home and community-based service systems in states and communities. Geographic coverage: Nationwide -- Administration for Community Living, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - February 5, 2019 Category: American Health Source Type: funding
Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-170 from the NIH Guide for Grants and Contracts. This purpose of this FOA is to identify risk factors for dementia progression in PDD. Applicants must have access to well-characterized populations of PDD patients that have been followed longitudinally that they can continue to follow with clinical assessments and biospecimen collection until autopsy. Research should propose to identify clinical, pathological and/or biospecimen factors that predict which patients will develop cognitive impairment and/or dementia. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 24, 2019 Category: Research Source Type: funding
Development and Validation of Advanced Mammalian Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-167 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages research to develop, characterize and validate innovative mammalian models that recapitulate molecular, cellular, neuropathological, behavioral and cognitive hallmarks of the Alzheimers Disease-Related Dementias (ADRD), including Lewy body dementia (LBD), vascular contributions to cognitive impairment and dementia (VCID), frontotemporal degeneration (FTD) and mixed etiology dementias (MED). Models will be expected to exhibit a broad range of features characteristic of the dementia disorder b...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2019 Category: Research Source Type: funding
MRC-KHIDI UK-Korea Dementia Research Call 2019
(Source: MRC Funding Opportunities)
Source: MRC Funding Opportunities - December 21, 2018 Category: Research Source Type: funding
Geriatric Workforce Enhancement Program
Grants to establish and operate geriatric education centers that will work to equip the primary care workforce and develop a healthcare workforce that maximizes patient and family engagement and improves health outcomes for older adults by integrating geriatrics and primary care. Special emphasis is on providing the primary care workforce with the knowledge and skills to care for older adults and partnering with community-based organizations to address gaps in healthcare for older adults, promote age-friendly health systems and dementia-friendly communities, and address the social determinants of health. Geographic coverag...
Source: Funding opportunities via the Rural Health Information Hub - November 13, 2018 Category: American Health Source Type: funding
Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-20-004 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for P30 Alzheimer's Disease Research Centers. NIA-designated Alzheimer's Disease Research Centers (ADRCs) serve as major sources of discovery into the nature of Alzheimers disease (AD) and related dementias and into the development of more effective approaches to prevention, diagnosis, care, and therapy. They contribute significantly to the development of shared resources that support dementia-relevant research, and they collaborate and coordinate their research efforts with oth...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 2, 2018 Category: Research Source Type: funding
Centers on the Demography and Economics of Alzheimer's Disease and Alzheimer's Related Dementias (P30 Clinical Trial Optional)
Funding Opportunity RFA-AG-20-002 from the NIH Guide for Grants and Contracts. This FOA invites Research and Development Center (P30) grant applications in demography, economics and health services research relevant to Alzheimer's Disease and Alzheimer's Related Dementias (AD/ADRD). Areas of focus that are especially encouraged are: a) National and international population trends in cognitive aging and AD/ADRD; b) Demography of dementia care and caregiving; c) Economic burden of AD/ADRD; d) Impact of health care systems and long-term supports and services on outcomes for persons with dementia and their care providers; e...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 30, 2018 Category: Research Source Type: funding
Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-19-013 from the NIH Guide for Grants and Contracts. This FOA invites applications that will systematically and comprehensively characterize alpha-synuclein and amyloid-beta subspecies present in human Lewy Body Dementia (LBD) post-mortem brain tissue, identify toxic subspecies and potential mechanisms of toxicity, and characterize any interactions between the proteins that may contribute to increased toxicity and/or explain selective vulnerabilities of cells/circuits. Applications are required to include at least 3 hypothesis-driven projects that address these goals, an administrative core, an...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 29, 2018 Category: Research Source Type: funding
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R01 Clinical Trial Optional)
Funding Opportunity RFA-MH-19-510 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings from such research are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS, and may provide clues to novel intervention targets for alleviating some of the burden associated with these symptoms, or ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2018 Category: Research Source Type: funding
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R21 Clinical Trial Optional)
Funding Opportunity RFA-MH-19-511 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD).The findings from such research are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS, and may provide insights into novel targets for interventions that might alleviatesomeburden associated with these symptoms...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2018 Category: Research Source Type: funding
NIA AD/ADRD Health Care Systems Research Collaboratory (U54 - Clinical Trial Required)
Funding Opportunity RFA-AG-19-009 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the AD/ADRD Health Care Systems Research Collaboratory (Collaboratory, henceforth) to improve care for persons with dementia (PWD) and their caregivers through health systems. Health and long-term systems for this FOA are defined broadly and include organizations providing care across settings to include primary and specialty outpatient care, acute inpatient care, skilled nursing and other rehabilitation facilities, residential long-term care, and home and community-based services. Organi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 25, 2018 Category: Research Source Type: funding
Edward R. Roybal Coordinating Center (R24 - Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-19-008 from the NIH Guide for Grants and Contracts. This FOA invites applications from qualified institutions to create a Roybal Center Coordinating Center (CC), serving the needs of the Roybal Centers for Translational Research on Aging program as well as the Roybal Centers for Translational Research on Dementia Care Provider Support program. The Roybal Coordinating Center will serve as a hub for the Roybal Center grant program. Roybal Center programs conduct translational in the behavioral and social sciences of aging, structured in accordance with the NIH Stage Model. Roybal Center program ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 7, 2018 Category: Research Source Type: funding
